Adynxx's Series B Round

Adynxx raised a round of funding on January 10, 2017.

Adynxx is a clinical-stage pharmaceutical company developing a platform of therapeutics for the prevention and resolution of chronic pain at its molecular roots, preventing the development of pain fol…

Articles about Adynxx's Series B Round: